Summary N 6-methyladenosine (m 6 A) is the most abundant internal modification of
mRNAs and is implicated in all aspects of post-transcriptional RNA metabolism. However …

Breast cancer is a heterogeneous disease and one of the most common cancers among
women. Recently, microRNAs (miRNAs) have been used as biomarkers due to their …

MicroRNAs are small RNAs with ability to attach to the large number of RNA that regulate
gene expression on post-transcriptional level via inhibition or degradation of specific …

Copy number alterations are widespread in cancer genomes and are part of the genomic
instability underlying the pathogenesis of neoplastic diseases. Recurrent copy number …

MicroRNAs (miRNAs) comprise a class of short, non-coding RNAs that directly target 3′
UTR of mRNA, causing subsequent degradation or suppression of translation. Here, we …

Papillary thyroid cancer (PTC) has a continuously increasing incidence and imposes a
heavy medical burden to individuals and society due to its high proportion of lymph node …

Breast cancer is one of the most common malignancies and a major cause of cancer-related
mortality all over the world. A growing body of reports revealed that microRNAs play …

Estrogen receptor α (ERα) is an important biomarker of breast cancer severity and a
common therapeutic target. In response to estrogen, ERα stimulates a dynamic …

Studies have shown that microRNAs (miRNAs) can promote or suppress tumor growth and
therefore act as targets for cancer therapy. Hsa-miR-503-5p, a mature miRNA derived from …

Microarray data analyses were performed to search for metastasis-associated oncogenes in
prostate cancer (PCa). RNF31 mRNA expressions in tumor tissues and benign prostate …